Cargando…

Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody

To explore the potential of using non-human coronaviruses for cancer therapy, we first established their ability to kill human tumor cells. We found that the feline infectious peritonitis virus (FIPV) and a felinized murine hepatitis virus (fMHV), both normally incapable of infecting human cells, co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Würdinger, T, Verheije, M H, Raaben, M, Bosch, B J, de Haan, C A M, van Beusechem, V W, Rottier, P J M, Gerritsen, W R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2005
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091791/ https://www.ncbi.nlm.nih.gov/pubmed/15843808 http://dx.doi.org/10.1038/sj.gt.3302535

Ejemplares similares

Antibody-mediated targeting of viral vectors to the Fc receptor expressed on acute myeloid leukemia cells
por: Würdinger, T, et al.
Publicado: (2006)

455. Targeting of a Non-Human Coronavirus to Human Tumor Cells by Using a Bispecific Single-Chain Antibody
Publicado: (2003)

Mouse Hepatitis Coronavirus RNA Replication Depends on GBF1-Mediated ARF1 Activation
por: Verheije, Monique H., et al.
Publicado: (2008)

Strategies for Bispecific Single Chain Antibody in Cancer Immunotherapy
por: Zhou, Shu-juan, et al.
Publicado: (2017)

First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach
por: Schaller, Teilo H, et al.
Publicado: (2020)

Type I interferon receptor-independent and -dependent host transcriptional responses to mouse hepatitis coronavirus infection in vivo
por: Raaben, Matthijs, et al.
Publicado: (2009)

Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha.
por: Schmidt, M., et al.
Publicado: (1996)

Construction and expression of D-dimer and GPIIb/IIIa single-chain bispecific antibody
por: DAN, ZHAOKUI, et al.
Publicado: (2013)

Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner
por: Burkard, Christine, et al.
Publicado: (2014)

Single-Chain Variable Fragment-Based Bispecific Antibodies: Hitting Two Targets with One Sophisticated Arrow
por: Ahamadi-Fesharaki, Raoufeh, et al.
Publicado: (2019)

Retargeting of Viruses to Generate Oncolytic Agents
por: Verheije, M. H., et al.
Publicado: (2012)

Molecular Interactions in the Assembly of Coronaviruses
por: de Haan, Cornelis A.M., et al.
Publicado: (2005)

Manipulation of the Coronavirus Genome Using Targeted RNA Recombination with Interspecies Chimeric Coronaviruses
por: de Haan, Cornelis A.M., et al.
Publicado: (2007)

The state of the art of bispecific antibodies for treating human malignancies
por: Wang, Shuhang, et al.
Publicado: (2021)

Functional comparison of single-chain and two-chain anti-CD3-based bispecific antibodies in gene immunotherapy applications
por: Compte, Marta, et al.
Publicado: (2014)

Secreted and tumour targeted human carboxylesterase for activation of irinotecan
por: Oosterhoff, D, et al.
Publicado: (2002)

Bispecific Antibodies and Gene Therapy
por: Nettelbeck, Dirk M.
Publicado: (2011)

Adaptation of novel H7N9 influenza A virus to human receptors
por: Dortmans, J. C. F. M., et al.
Publicado: (2013)

Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics
por: Ching, Kathryn H., et al.
Publicado: (2021)

Effects of different interchain linkers on biological activity of an anti-prostate cancer single-chain bispecific antibody
por: Hao, Chao-hui, et al.
Publicado: (2015)

A human IgE bispecific antibody shows potent cytotoxic capacity mediated by monocytes
por: Vukovic, Natasa, et al.
Publicado: (2022)

Investigation of the effect of salt additives in Protein L affinity chromatography for the purification of tandem single-chain variable fragment bispecific antibodies
por: Chen, Serene W., et al.
Publicado: (2020)

EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies
por: Cooke, Heather A., et al.
Publicado: (2018)

CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies
por: Fernández-Quintero, Monica L., et al.
Publicado: (2022)

Nanocell targeting using engineered bispecific antibodies
por: Taylor, Karin, et al.
Publicado: (2014)

Biogenesis and Dynamics of the Coronavirus Replicative Structures
por: Hagemeijer, Marne C., et al.
Publicado: (2012)

A reverse genetics system for avian coronavirus infectious bronchitis virus based on targeted RNA recombination
por: van Beurden, Steven J., et al.
Publicado: (2017)

Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6
por: Stadler, Christiane R., et al.
Publicado: (2015)

T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma
por: Verkleij, Christie P.M., et al.
Publicado: (2020)

Bispecific antibodies and their applications
por: Fan, Gaowei, et al.
Publicado: (2015)

The making of bispecific antibodies
por: Brinkmann, Ulrich, et al.
Publicado: (2017)

Recombinant Bispecific Antibodies to the Human ErbB2 Receptor and Interferon-Beta
por: Panina, A. A., et al.
Publicado: (2020)

Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy
por: Huang, Shuyu, et al.
Publicado: (2020)

Design and Production of Bispecific Antibodies
por: Wang, Qiong, et al.
Publicado: (2019)

A human bispecific antibody neutralizes botulinum neurotoxin serotype A
por: Lu, Jiansheng, et al.
Publicado: (2023)

Clinical Pharmacology and Translational Aspects of Bispecific Antibodies
por: Trivedi, A, et al.
Publicado: (2017)

Improved microarray gene expression profiling of virus-infected cells after removal of viral RNA
por: Raaben, Matthijs, et al.
Publicado: (2008)

A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.
por: Pimm, M. V., et al.
Publicado: (1990)

Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.
por: Embleton, M. J., et al.
Publicado: (1991)

Bispecific antibody-derived molecules to target persistent HIV infection
por: Nordstrom, Jeffrey L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6npa4m66aji66i8get8j4h4k50